These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31898401)
1. N-locking stabilization of covalent helical peptides: Application to Bfl-1 antagonists. Baggio C; Udompholkul P; Gambini L; Jossart J; Salem AF; Håkansson M; Perry JJP; Pellecchia M Chem Biol Drug Des; 2020 Apr; 95(4):412-426. PubMed ID: 31898401 [TBL] [Abstract][Full Text] [Related]
2. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent. Modi V; Lama D; Sankararamakrishnan R J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956 [TBL] [Abstract][Full Text] [Related]
3. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor. Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033 [TBL] [Abstract][Full Text] [Related]
4. Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1. Jenson JM; Ryan JA; Grant RA; Letai A; Keating AE Elife; 2017 Jun; 6():. PubMed ID: 28594323 [TBL] [Abstract][Full Text] [Related]
5. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides. Modi V; Sankararamakrishnan R J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820 [TBL] [Abstract][Full Text] [Related]
6. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide. Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and helical structure of lactam bridged BH3 peptides derived from pro-apoptotic Bcl-2 family proteins. Yang B; Liu D; Huang Z Bioorg Med Chem Lett; 2004 Mar; 14(6):1403-6. PubMed ID: 15006371 [TBL] [Abstract][Full Text] [Related]
8. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Lama D; Sankararamakrishnan R Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209 [TBL] [Abstract][Full Text] [Related]
10. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study. Chen Y; Wang J; Zhang J; Wang W J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527 [TBL] [Abstract][Full Text] [Related]
12. Cellular Uptake and Ultrastructural Localization Underlie the Pro-apoptotic Activity of a Hydrocarbon-stapled BIM BH3 Peptide. Edwards AL; Wachter F; Lammert M; Huhn AJ; Luccarelli J; Bird GH; Walensky LD ACS Chem Biol; 2015 Sep; 10(9):2149-57. PubMed ID: 26151238 [TBL] [Abstract][Full Text] [Related]
13. Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins. Foight GW; Keating AE J Mol Biol; 2015 Jul; 427(15):2468-2490. PubMed ID: 26009469 [TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members. Santiveri CM; Sborgi L; de Alba E J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964 [TBL] [Abstract][Full Text] [Related]
15. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Rajan S; Choi M; Baek K; Yoon HS Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960 [TBL] [Abstract][Full Text] [Related]
16. An anthraquinone scaffold for putative, two-face Bim BH3 α-helix mimic. Zhang Z; Li X; Song T; Zhao Y; Feng Y J Med Chem; 2012 Dec; 55(23):10735-41. PubMed ID: 23167494 [TBL] [Abstract][Full Text] [Related]
17. NMR studies of interactions between Bax and BH3 domain-containing peptides in the absence and presence of CHAPS. Yao S; Westphal D; Babon JJ; Thompson GV; Robin AY; Adams JM; Colman PM; Czabotar PE Arch Biochem Biophys; 2014 Mar; 545():33-43. PubMed ID: 24434006 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. Oberstein A; Jeffrey PD; Shi Y J Biol Chem; 2007 Apr; 282(17):13123-32. PubMed ID: 17337444 [TBL] [Abstract][Full Text] [Related]
19. Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity. Okamoto T; Zobel K; Fedorova A; Quan C; Yang H; Fairbrother WJ; Huang DC; Smith BJ; Deshayes K; Czabotar PE ACS Chem Biol; 2013 Feb; 8(2):297-302. PubMed ID: 23151250 [TBL] [Abstract][Full Text] [Related]
20. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents. Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]